Your account is not claimed yet. You can sign up with ORCID to claim your account.

Miguel Viñas

ResearcherID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 17

Top Venues

Antibiotics (Basel, Switzerland)

BMC oral health

Pharmaceutics

Microorganisms

University of Barcelona

University of Barcelona (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Barcelona Jan 13o 2002

Spain

Full Professor :: Pathology & Experimental therapeutics

Education History

University of Barcelona - Oct 9o 1981

Spain

PHD :: Microbiology

Publications

Paula Espinal, Ester Fusté, Josep M Sierra, Guadalupe Jiménez-Galisteo, Teresa Vinuesa, Miguel Viñas
Progress towards the clinical use of antimicrobial peptides: challenges and opportunities. Expert opinion on biological therapy (2023)
Angela Trejo, Carme Masdeu, Irene Serrano-Pérez, Marina Pedrola, Narcís Juanola, Ouldouz Ghashghaei, Guadalupe Jiménez-Galisteo, Rodolfo Lavilla, Francisco Palacios, Concepcion Alonso, Miguel Viñas
Efficient AntiMycolata Agents by Increasing the Lipophilicity of Known Antibiotics through Multicomponent Reactions. Antibiotics (Basel, Switzerland) 12 (1) (2023)
Eulàlia Sans-Serramitjana, Macarena Obreque, Fernanda Muñoz, Carlos Zaror, Maria de la Luz Mora, Miguel Viñas, Pablo Betancourt
Antimicrobial Activity of Selenium Nanoparticles (SeNPs) against Potentially Pathogenic Oral Microorganisms: A Scoping Review. Pharmaceutics 15 (9) (2023)
Angela Trejo, Carme Masdeu, Irene Serrano-Pérez, Marina Pedrola, Narcís Juanola, Ouldouz Ghashghaei, Guadalupe Jiménez-Galisteo, Rodolfo Lavilla, Francisco Palacios, Concepcion Alonso, Miguel Viñas
Efficient AntiMycolata Agents by Increasing the Lipophilicity of Known Antibiotics through Multicomponent Reactions. Antibiotics (Basel, Switzerland) 12 (1) (2023)
Eric Fernández-De La Cruz, Joanna Wessely-Szponder, Miguel Viñas, Teresa Vinuesa, Alexandra Merlos, Marta Jorba, Paula Espinal, Ester Fusté
Native Pig Neutrophil Products: Insights into Their Antimicrobial Activity. Microorganisms 11 (8) (2023)
Felipe-Rodrigo Aguilera, Miguel Viñas, Josep M Sierra, Teresa Vinuesa, Antonio R Fernández de Henestrosa, Marta Furmanczyk, Carles Trullas, Eric Jourdan, José López-López, Marta Jorba
Substantivity of mouth-rinse formulations containing cetylpyridinium chloride and O-cymen-5-ol: a randomized-crossover trial. BMC oral health 22 (1) (2022)
Elena de Planell-Mas, Blanca Martínez-Garriga, Miguel Viñas, Antonio J Zalacain-Vicuña
Efficacy of the Treatment of Plantar Warts Using 1064 nm Laser and Cooling. International journal of environmental research and public health 19 (2) (2022)
Isabel Pérez-Guillén, Oscar Domenech, Adrià Botet-Carreras, Alexandra Merlos, Josep M Sierra, Fernando Albericio, Beatriz G de la Torre, M Teresa Montero, Miguel Viñas, Jordi H Borrell
Studying Lipid Membrane Interactions of a Super-Cationic Peptide in Model Membranes and Living Bacteria. Pharmaceutics 14 (10) (2022)
Felipe-Rodrigo Aguilera, Miguel Viñas, Josep M Sierra, Teresa Vinuesa, Antonio R Fernández de Henestrosa, Marta Furmanczyk, Carles Trullas, Eric Jourdan, José López-López, Marta Jorba
Substantivity of mouth-rinse formulations containing cetylpyridinium chloride and O-cymen-5-ol: a randomized-crossover trial. BMC oral health 22 (1) (2022)
Lorena Patrícia Gaviria, Lourdes Montsant, Carlos Azuaje, Aida González-Díaz, Juan Pablo Horcajada, Enric Limón, Miguel Viñas, Paula Espinal, Ester Fusté
A Descriptive Analysis of Urinary ESBL-Producing- Escherichia coli in Cerdanya Hospital. Microorganisms 10 (3) (2022)
Felipe-Rodrigo Aguilera, Miguel Viñas, Josep M Sierra, Teresa Vinuesa, Antonio R Fernández de Henestrosa, Marta Furmanczyk, Carles Trullas, Eric Jourdan, José López-López, Marta Jorba
Substantivity of mouth-rinse formulations containing cetylpyridinium chloride and O-cymen-5-ol: a randomized-crossover trial. BMC oral health 22 (1) (2022)
Rocío Herráez, Roberto Quesada, Norma Dahdah, Miguel Viñas, Teresa Vinuesa
Tambjamines and Prodiginines: Biocidal Activity against Trypanosoma cruzi. Pharmaceutics 13 (5) (2021)
Josep M Sierra, Miguel Viñas
Future prospects for Antimicrobial peptide development: peptidomimetics and antimicrobial combinations. Expert opinion on drug discovery 16 (6) (2021)
Marta Jorba, Marina Pedrola, Ouldouz Ghashghaei, Rocío Herráez, Lluis Campos-Vicens, Francisco Javier Luque, Rodolfo Lavilla, Miguel Viñas
New Trimethoprim-Like Molecules: Bacteriological Evaluation and Insights into Their Action. Antibiotics (Basel, Switzerland) 10 (6) (2021)
Estelle J Ramchuran, Isabel Pérez-Guillén, Linda A Bester, Rene B Khan, Fernando Albericio, Miguel Viñas, Beatriz G de la Torre
Super-Cationic Peptide Dendrimers-Synthesis and Evaluation as Antimicrobial Agents. Antibiotics (Basel, Switzerland) 10 (6) (2021)
Helena Martin-Gómez, Marta Jorba, Fernando Albericio, Miguel Viñas, Judit Tulla-Puche
Chemical Modification of Microcin J25 Reveals New Insights on the Stereospecific Requirements for Antimicrobial Activity. International journal of molecular sciences 20 (20) (2019)
Elisabet Mauri-Obradors, Alexandra Merlos, Albert Estrugo-Devesa, Enric Jané-Salas, Teresa Vinuesa, Miguel Viñas
Benefits of non-surgical periodontal treatment in patients with type 2 diabetes mellitus and chronic periodontitis: A randomized controlled trial. Journal of clinical periodontology 45 (3) (2018)

Miguel Viñas.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Miguel Viñas